- Title
- Post-hoc survival outcomes based on initial and subsequent treatment in patients with mmrp/MSS primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
- Creators
- Dominik Denschlag - Head of the Department OB/GYN, Director of Breast- and Gynecologic Oncology Cancer Center, Hochtaunus-kliniken, Bad Homburg, GermanyMatthew A. Powell - Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri, United StatesHenrik Roed - Copenhagen University HospitalLucy Gilbert - McGill University Health CentreOleksandr Zub - Chernihiv Medical Center of Modern Oncology, Chernihiv Regional Council, Chernihiv, UkraineCarolyn Mccourt - Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri, United StatesEvelyn Fleming - Dartmouth–Hitchcock Medical CenterRoberto Angioli - MedicoNoelle Cloven - Fondazione Ricerca TraslazionaleKathryn Pennington - University of Washington School of MedicineBradley J. Monk - Gynecologic Oncology Groupet al.
- Publication Details
- International journal of gynecological cancer, Vol.36(2), p.104434
- Publisher
- Elsevier Inc
- Identifiers
- 991006256657002656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Post-hoc survival outcomes based on initial and subsequent treatment in patients with mmrp/MSS primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
International journal of gynecological cancer, Vol.36(2), p.104434
02/2026
Metrics
1 Record Views